Antibody therapies set to transform respiratory syncytial virus prevention for babies

被引:0
作者
Elie Dolgin
机构
来源
Nature | 2023年 / 621卷
关键词
Drug discovery; Health care; Medical research; Vaccines;
D O I
暂无
中图分类号
学科分类号
摘要
Drugs that counter RSV infection can safeguard newborns, offering another mode of protection alongside vaccines.
引用
收藏
页码:S55 / S57
相关论文
共 13 条
[1]  
Kieffer A.(2022)undefined J. Infect. Dis. 226 S282-S292
[2]  
Wilkins D.(2023)undefined Nature Med. 29 1172-1179
[3]  
Hammitt L. L.(2022)undefined N. Engl. J. Med. 386 837-846
[4]  
Muller W. J.(2023)undefined N. Engl. J. Med. 388 1533-1534
[5]  
Nourbakhsh S.(2021)undefined EClinicalMedicine 41 101141-1464
[6]  
Kampmann B.(2023)undefined N. Engl. J. Med. 388 1451-425
[7]  
Griffin M. P.(2020)undefined N. Engl. J. Med. 383 415-e4408
[8]  
Simões E. A. F.(2021)undefined Clin. Infect. Dis. 73 e4400-866
[9]  
Lu B.(2019)undefined Sci. Rep. 9 3898-1557
[10]  
Tabor D. E.(2020)undefined J. Clin. Microbiol. 59 e01828-20-undefined